• 充值
  • 帮助
搜期刊
主题
文献检索

Antioxidants & Redox Signaling CA PubMed AJ SCIE JCR:Q1 中科院2区
发文量 5,715
被引量 336,560
影响因子(2023) 6.841

Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas. ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes. ARS coverage includes: -ROS/RNS as messengers -Gaseous signal transducers -Hypoxia and tissue oxygenation -microRNA -Prokaryotic systems -Lessons from plant biology

  • 主办单位： MARY ANN LIEBERT, INC
  • 出版地区： United States
  • 出版周期： 双周刊
  • 别名： 抗氧化剂与氧化还原信号
  • 国际标准连续出版物号： ISSN 1523-0864
  • 创刊时间： 1999年
收录汇总 栏目浏览 期刊详情
收录汇总
出版文献
期刊详情
分析评价
  • 1
  • 2
  • 3
  • 4
  • 5
目录
封面
2024年7-9期
共：9篇
2024年7-9期

2024年7-9期

客服咨询
投稿相关：023-63416211
撤稿相关：023-67396862
查重相关：023-63506028
重庆维普资讯有限公司 渝B2-20050021-1 渝公网备 50019002500403
违法和不良信息举报中心   举报邮箱：jubao@cqvip.com   互联网算法推荐专项举报：sfjubao@cqvip.com    网络暴力专项举报: bljubao@cqvip.com
网络出版：（署）网出证（渝）字第014号    出版物经营许可证：新出发2018批字第006号